Citigroup
SWAV

Citigroup’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Citigroup’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,310
Closed -$5.31M – 5844
2024
Q1 		$5.31M Sell
16,310
-507
-3% -$124K ﹤0.01% 1666
2023
Q4 		$3.2M Buy
16,817
+13,059
+347% +$2.47M ﹤0.01% 1896
2023
Q3 		$748K Sell
3,758
-14,980
-80% -$3.54M ﹤0.01% 2750
2023
Q2 		$5.35M Buy
18,738
+12,274
+190% +$3.41M ﹤0.01% 1453
2023
Q1 		$1.4M Buy
6,464
+27
+0.4% +$5.26K ﹤0.01% 2289
2022
Q4 		$1.32M Sell
6,437
-4,503
-41% -$1.14M ﹤0.01% 2369
2022
Q3 		$3.04M Buy
10,940
+4,687
+75% +$1.19M ﹤0.01% 1852
2022
Q2 		$1.2M Buy
6,253
+888
+17% +$157K ﹤0.01% 2512
2022
Q1 		$1.11M Sell
5,365
-9,518
-64% -$1.57M ﹤0.01% 2866
2021
Q4 		$2.65M Buy
14,883
+4,766
+47% +$940K ﹤0.01% 2390
2021
Q3 		$2.08M Buy
10,117
+3,530
+54% +$693K ﹤0.01% 2512
2021
Q2 		$1.25M Sell
6,587
-6,961
-51% -$1.14M ﹤0.01% 3057
2021
Q1 		$1.76M Buy
13,548
+2,614
+24% +$314K ﹤0.01% 2581
2020
Q4 		$1.13M Buy
10,934
+5,307
+94% +$460K ﹤0.01% 3413
2020
Q3 		$426K Sell
5,627
-6,349
-53% -$360K ﹤0.01% 3989
2020
Q2 		$567K Buy
11,976
+659
+6% +$27.1K ﹤0.01% 4130
2020
Q1 		$376K Buy
11,317
+6,075
+116% +$241K ﹤0.01% 4143
2019
Q4 		$230K Buy
5,242
+4,914
+1,498% +$181K ﹤0.01% 5073
2019
Q3 		$10K Sell
328
-4,659
-93% -$198K ﹤0.01% 7092
2019
Q2 		$284K Buy
4,987
+1,007
+25% +$48.9K ﹤0.01% 4968
2019
Q1 		$133K Buy
+3,980
New +$132K ﹤0.01% 5479

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup's SWAV Position: Q2 2024 in Review

Citigroup sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 16,310 shares — an estimated $5.31M sold.

Citigroup first reported a position in SWAV in Q1 2019 and held it in 21 quarters. The position peaked at $5.35M in Q2 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Citigroup reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Citigroup sold 16,310 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $5.31M.
  • Citigroup first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 21 quarters.
  • Citigroup's Shockwave Medical, Inc. Common Stock position peaked at $5.35M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Citigroup's 13F filing for Q2 2024, filed 12 Aug 2024.